CEO & Co-Founder Opportunity | Deeptech BioEngineering | Drug Discovery
Are you looking for an entrepreneurial opportunity at the intersection of microfluidics, advanced in‑vitro models and drug discovery, with the chance to build a high‑impact deep‑tech spin‑off?
OGYX is developing a cost‑effective, robust and user‑friendly microfluidic Organ‑on‑a‑Chip platform designed for high‑throughput in‑vitro assays in research, drug development and toxicology. Backed by Leitat and a strong technical team, the project is now seeking an entrepreneurial CEO to lead the creation of the spin‑off and drive its commercial and strategic development.
As CEO & Co-Founder, you will lead the venture‑building journey together with the scientific and technical team, shaping the business model, early market traction and fundraising strategy of a company with the potential to become a preferred platform provider in the Orga...